This is a firm fixed-price purchase order awarded by the National Cancer Institute to Akoya Biosciences, Inc. (doing business as Phenoptics), a self-certified small disadvantaged business manufacturer of goods, for a service contract to provide a PhenoCycler instrument. The total ceiling value of the contract is $10,020.00, and the ultimate completion date is July 30, 2025. The award is not associated with a set-aside program. Akoya Biosciences is a biotechnology company that specializes in spatial phenotyping and advanced tissue imaging solutions, providing a range of products and services to federal agencies such as the Department of Veterans Affairs and the National Institutes of Health, including imaging systems, reagents, software, and maintenance. This contract supports the National Cancer Institute's Spatial Tissue Exploration Program of Human Central Nervous System Tumors.
Generated 8/1/24, 9:10 AM